Targeting CD38 with Daratumumab Suppresses B-Cell Receptor Signaling and Enhances the Activity of Ibrutinib in Waldenstrom Macroglobulinemia Cells

被引：0
|
作者：
Paulus, Aneel
Manna, Alak
Akhtar, Sharoon
Sher, Taimur
Roy, Vivek
Coleman, Morton
Novak, Anne J.
Ansell, Stephen M.
Malavasi, Fabio
Ailawadhi, Sikander
Chanan-Khan, Asher A.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1529
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Targeting CD38 with daratumumab is lethal to Waldenstrom macroglobulinaemia cells
    Paulus, Aneel
    Manna, Alak
    Akhtar, Sharoon
    Paulus, Shumail M.
    Sharma, Mayank
    Coignet, Marie V.
    Jiang, Liuyan
    Roy, Vivek
    Witzig, Thomas E.
    Ansell, Stephen M.
    Allan, John
    Furman, Richard
    Aulakh, Sonikpreet
    Manochakian, Rami
    Ailawadhi, Sikander
    Chanan-Khan, Asher A.
    Sher, Taimur
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 183 (02) : 196 - 211
  • [2] Drug Resistance Alters CD38 Expression and in Vitro Response to Daratumumab in Waldenstrom Macroglobulinemia Cells
    Paulus, Aneel
    Akhtar, Sharoon
    Bashir, Yamima
    Paulus, Shumail M.
    Yousaf, Hassan
    Roy, Vivek
    Ailawadhi, Sikander
    Ansell, Stephen
    Witzig, Thomas E.
    Chanan-Khan, Asher A.
    BLOOD, 2016, 128 (22)
  • [3] Daratumumab Mitigates B-Cell Receptor Signaling and Enhances Antitumor Activity of Ibrutinib in Chronic Lymphocytic Leukemia (CLL) Cells
    Manna, Alak
    Akhtar, Sharoon
    Meghji, Zahara
    Bhatia, Kirtipal
    Yi, Paul
    Parikh, Sameer A.
    Ding, Wei
    Leis, Jose F.
    Sher, Taimur
    Malavasi, Fabio
    Alegria, Victoria R.
    Ailawadhi, Sikander
    Chanan-Khan, Asher A.
    Paulus, Aneel
    BLOOD, 2017, 130
  • [4] Targeting CD38 Enhances the Antileukemic Activity of Ibrutinib in Chronic Lymphocytic Leukemia
    Manna, Alak
    Aulakh, Sonikpreet
    Jani, Prachi
    Ahmed, Salman
    Akhtar, Sharoon
    Coignet, Marie
    Heckman, Michael
    Meghji, Zahara
    Bhatia, Kirtipal
    Sharma, Aarushi
    Sher, Taimur
    Alegria, Victoria
    Malavasi, Fabio
    Chini, Eduardo N.
    Chanan-Khan, Asher
    Ailawadhi, Sikander
    Paulus, Aneel
    CLINICAL CANCER RESEARCH, 2019, 25 (13) : 3974 - 3985
  • [5] CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells
    Deaglio, S
    Capobianco, A
    Bergui, L
    Dürig, J
    Morabito, F
    Dührsen, U
    Malavasi, F
    BLOOD, 2003, 102 (06) : 2146 - 2155
  • [6] Targeting CD38 with Daratumumab Plus Chemotherapy for Patients with Advanced-Stage Plasmablastoid Large B-Cell Lymphoma
    Ryu, Yun Kyoung
    Ricker, Edd C.
    Soderquist, Craig R.
    Francescone, Mark A.
    Lipsky, Andrew H.
    Amengual, Jennifer E.
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (16)
  • [7] Clonal B cells in Waldenstrom's macroglobulinemia exhibit functional features of chronic active B-cell receptor signaling
    Argyropoulos, K. V.
    Vogel, R.
    Ziegler, C.
    Altan-Bonnet, G.
    Velardi, E.
    Calafiore, M.
    Dogan, A.
    Arcila, M.
    Patel, M.
    Knapp, K.
    Mallek, C.
    Hunter, Z. R.
    Treon, S. P.
    van den Brink, M. R. M.
    Palomba, M. L.
    LEUKEMIA, 2016, 30 (05) : 1116 - 1125
  • [8] B-CELL TRIGGERING VIA CD38
    HOWARD, M
    SANTOSARGUMEDO, L
    GRIMALDI, C
    BAZAN, F
    HARADA, N
    PARKHOUSE, M
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 197 - 197
  • [9] B-CELL TRIGGERING VIA CD38
    HOWARD, M
    SANTOSARGUMEDO, L
    GRIMALDI, C
    BAZAN, F
    HARADA, N
    PARKHOUSE, M
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 159 - 159
  • [10] Efficient Targeting of CD38 in Mature T-Cell Neoplasms with Daratumumab and Allogeneic NK Cells
    Johnson, William T.
    Isabelle, Colleen
    Vogel, Ashley N.
    Brammer, Jonathan E.
    Boles, Amy E.
    McConnell, Kathleen
    Berge, Robyn
    Nisenfeld, Liam
    Uppal, Guldeep
    Gong, Jerald
    Chakravarti, Nitin
    Porcu, Pierluigi
    Mishra, Anjali
    BLOOD, 2021, 138
12345